Você procurou por: mikrobijoloġika (Maltês - Inglês)

suxxettibilità mikrobijoloġika
microbiological susceptibility

8 suxxettibilitċa mikrobijoloġika
8 microbiological susceptibility

post ta’ sigurtà mikrobijoloġika
microbiological safety post

investigazzjoni mikrobijoloġika ta’ l-additiv
microbiological investigation of the additive

minn perspettiva mikrobijoloġika, is- soluzzjoni trid tintuża immedjatament.
from a microbiological point of view, the solution must be used immediately.

minn perspettiva mikrobijoloġika, il-prodott għandu jintuża immedjatament.
from a microbiological point of view, the product should be used immediately.

mid-derha mikrobijoloġika, dan il-prodott għandu jintuża minnufih.
from a microbiological point of view, the product should be used immediately.

mill-perspettiva mikrobijoloġika, il-prodott mediċinali għandu jintuża minnufih.
from a microbiological point of view, the medicinal product should be used immediately.

minn perspettiva mikrobijoloġika, il-prodott mediċinali għandu jintuża mill-ewwel.
from a microbiological point of view, the medicinal product should be used immediately.

mil-lat tas-sigurtà mikrobijoloġika, il-prodott għandu jintuża immedjatament.
from a microbiological safety point of view, the product should be used immediately.

minn perspettiva mikrobijoloġika, il-boroż tal-infużjoni preparati għandhom jintużaw minnufih.
from a microbiological point of view, the prepared infusion bags should be used immediately.

il-kondizzjoni mikrobijoloġika u iġjeniċi tal-prodotti b'bażi ta' ħalib;
the microbiological and hygienic condition of the milk-based products;

minn perspettiva mikrobijoloġika, il-prodott għandu jintuża immedjatament wara li jkun miżjud bl- ilma.
from a microbiological point of view, the product should be used immediately after dilution.

rispons favorevoli kien jeħtieġ kemm għibien tas-sintomi kif ukoll tneħħija mikrobijoloġika tal-infezzjoni candida.
a favourable response required both symptom resolution and microbiological clearance of the candida infection.

mill-aspett ta’ sigurta’ mikrobijoloġika, il-prodott għandu jintuża’ immedjatament.
from a microbiological safety point of view, the product is to be used immediately.

l-iżgurar tal-kwalità tad-dokumentazzjoni mikrobijoloġika u r-rekords tal-pazjenti;
ensuring the quality of microbiological documentation and patient records;

il-metabolu l-aktar abbundanti huwa 8-hydroxy-ibafloxacin li għandu wkoll attività mikrobijoloġika.
the most abundant metabolite is 8-hydroxy-ibafloxacin, which is also microbiologically active.

wara r-rikostituzzjoni, il-prodott mediċinali għandu jiġi wżat immedjatament minħabba r-riskju ta’ kontaminazzjoni mikrobijoloġika
after reconstitution, the medicinal product should be used immediately due to the risk of microbiological contamination.

wara r-rikostituzzjoni, il-prodott mediċinali għandu jintuża minnufih minħabba r-riskju ta’ kontaminazzjoni mikrobijoloġika.
after reconstitution, the medicinal product should be used immediately due to the risk of microbiological contamination.

id- dokument ta ’ reazzjoni inkluda reviżjoni ta ’ dejta klinika (dejta, rapporti ta ’ riċerka medika ppubblikati) u dejta mikrobijoloġika.
the response document included a review of clinical data (published data, medical research reports) and microbiological data.